Keros Therapeutics Inc. (KROS)
NASDAQ · Healthcare
Keros Therapeutics Inc. Total Liabilities 2019–2025
Keros Therapeutics Inc. annual total liabilities history from 2019 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Keros Therapeutics Inc. total liabilities as of December 31, 2025: 34.9M, a 21.30% decrease year-over-year.
- Keros Therapeutics Inc. total liabilities for 2025 were 34.9M, a 21.30% decrease from 2024.
- Keros Therapeutics Inc. total liabilities for 2024 were 44.3M, a 17.25% increase from 2023.
- Keros Therapeutics Inc. total liabilities for 2023 were 37.8M, a 28.80% increase from 2022.
- Keros Therapeutics Inc. total liabilities for 2022 were 29.4M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Keros Therapeutics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $35 |
| 2024 | $44 |
| 2023 | $38 |
| 2022 | $29 |
| 2021 | $12 |
| 2020 | $8 |
| 2019 | $10 |
Keros Therapeutics Inc. Total Liabilities — FAQ
Keros Therapeutics Inc. (KROS) total liabilities over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see KROS's total liabilities history?
The chart and table above show Keros Therapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.